Meningococcal Disease in an International Traveler on Eculizumab Therapy - United States, 2015

被引：7

作者：

Applegate, Allen O. ^{[1
]}

Fong, Vanessa C. ^{[1
]}

Tardivel, Kara ^{[1
]}

Lippold, Susan A. ^{[1
]}

Zarate, Sheilah ^{[2
]}

机构：

[1] CDC, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA

[2] San Francisco Dept Publ Hlth, San Francisco, CA USA

来源：

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2016年 / 65卷 / 27期

关键词：

PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA;

D O I：

10.15585/mmwr.mm6527a3

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：696 / 697

页数：2

共 6 条

[1]

CDC, 2015, MEN WHO NEEDS VACC

[2]

CDC, 2015, PREV CONTR MEN DIS R

[3] FDA Report: Eculizumab (Soliris®) for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria [J].

Dmytrijuk, Andrew ;

Robie-Suh, Kathy ;

Cohen, Martin H. ;

Rieves, Dwaine ;

Weiss, Karen ;

Pazdur, Richard .

ONCOLOGIST, 2008, 13 (09) :993-1000

[4] Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria [J].

Hillmen, Peter ;

Muus, Petra ;

Roeth, Alexander ;

Elebute, Modupe O. ;

Risitano, Antonio M. ;

Schrezenmeier, Hubert ;

Szer, Jeffrey ;

Browne, Paul ;

Maciejewski, Jaroslaw P. ;

Schubert, Joerg ;

Urbano-Ispizua, Alvaro ;

de Castro, Carlos ;

Socie, Gerard ;

Brodsky, Robert A. .

BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (01) :62-73

[5]

O'Connor BA, 2005, COMMUN DIS INTELL, V29, P312

[6]

Riley LK, 2006, AVIAT SPACE ENVIR MD, V77, P758

← 1 →